Shaun Cordoba

This inventor holds 41 USPTO granted patents and 57 published patent applications, plus 7 CIPO patents and 20 EPO patents, primarily in Chimeric Antigen Receptors. Top assignees: Autolus Limited, Ucl Business Plc. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shaun Cordoba. Retrieved from https://idiyas.com/inventor/shaun-cordoba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41 (Patent Applications = 57)

% Patents Active = 95.1

CIPO Patents = 7 (Patent Applications = 27)

EPO Patents = 20 (Patent Applications = 68)

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 91(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Chimeric Antigen Receptor

Cytokine Receptor

T Cell Signalling

CAR T-Cells

Nucleic Acid Construct

Antigen Binding Domain

Cancer Treatment

Transcriptional Circuits

Polypeptide

Signalling System

CD19 Binding Domain

CD22 Binding Domain

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12624088 - CHIMERIC RECEPTOR COMPRISING A LIGAND BINDING DOMAIN AND AN ENDODOMAIN COMPRISING A CYTOKINE RECEPTOR ENDODOMAIN AND AN INTRACELLULAR T CELL SIGNALLING DOMAIN (2026-05-12),

2. 12516119 - ANTI TRBC1 ANTIGEN BINDING DOMAINS (2026-01-06),

3. 12496314 - Antigen-Binding Domain (2025-12-16),

4. 12492410 - Engineered Cytolytic Immunecell (2025-12-09),

5. 12454578 - Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen receptors (2025-10-28),

6. 12398194 - Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface (2025-08-26),

7. 12325733 - Binding domain (2025-06-10),

8. 12241068 - CD79-specific chimeric antigen receptor (2025-03-04),

9. 12234295 - Chimeric transmembrane protein comprising antibody dimerization domains and a type I cytokine receptor endodomain, encoding nucleic acids thereof and methods of use thereof (2025-02-25),

10. 12187769 - Cell (2025-01-07),

11. 12049510 - Chimeric antigen receptor (2024-07-30),

12. 11963981 - Chimeric antigen receptor (2024-04-23),

13. 11959084 - Nucleic acid construct (2024-04-16),

14. 11851672 - CAR T-cells comprising transcriptional circuits (2023-12-26),

15. 11701386 - Cell (2023-07-18),

Title: Shaun Cordoba: Innovating in Cytokine Research

Introduction

Shaun Cordoba is a prolific inventor based in London, Great Britain, known for his significant contributions to the field of cytokine research. With an impressive portfolio of 33 patents, Cordoba has made strides in creating innovative solutions that address complex biomedical challenges.

Latest Patents

Among his latest inventions is a patented chimeric transmembrane protein that integrates antibody dimerization domains with a type I cytokine receptor endodomain. This groundbreaking invention provides a chimeric cytokine receptor (CCR) that incorporates an exodomain capable of binding to various ligands, including tumor-secreted factors, chemokines, and cell-surface antigens. Additionally, he has developed a cell embodying a chimeric antigen receptor (CAR) that features either a constitutively active or inducible Signal Transducer and Activator of Transcription (STAT) molecule, pushing the boundaries of cell therapy.

Career Highlights

Cordoba has held key positions in notable companies including Autolus Limited and UCL Business Plc. His work in these organizations has solidified his reputation as a leading figure in the domain of immune-oncology and therapeutic proteins. His innovative approach and visionary thinking have not only resulted in numerous patents but also fueled advancements in treatment methodologies.

Collaborations

In his career, Cordoba has collaborated with distinguished professionals such as Martin Pulé and Simon Thomas. These collaborations have enriched his research endeavors, leading to groundbreaking inventions and further enhancing the effectiveness of immunotherapy and related fields.

Conclusion

Shaun Cordoba's contributions to innovations in cytokine research through his extensive patent portfolio have made a significant impact on biomedical science. His work continues to pave the way for future breakthroughs, demonstrating the importance of creativity and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.